1Fountoulakis KN, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. Journal of Affective Disorders, 2005 ; 86 ( 1 ) : 1-10.
2Keck PE, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry, 2003; 160 (9): 1651-1658.
3Bourin M, Auby P, Marcus RN, et al. Aripiprazole versus haloperidol for maintained treatment effect in acute mania. Abstract NR467 plus Poster. California: 156^th Annual Meeting of the American Psychiatric Association, 2003 ; 17-22.
4Octavio I, Stock E, Archibald D, et al. Long-term effects of aripiprazole on affective symptoms of schizophrenia. Eur Neuropsychopharmacol. 2004; 14 (suppl. 3) : S261.
5Thase ME, Jonas A, Khan A, et al. Aripiprazole Monotherapy in Non-Psychotic Bipolar Ⅰ Depression. J Clin Psychopharmacology, 2008 ; 28 ( 1 ) : 13-20.
6McElroy SL, Suppes T, Frye MA, et al. Open-label aripiprazole in the treatment of acute bipolar depression: A prospective pilot trial. Affect Disord. 2007; 101 (1-3) : 275-281.
7Dunn RT, Stan VA, Chriki IS, et al. A prospective open-label study of aripiprazole mono-and adjunctive treatment in acute bipolar depression. Affect Disord. 2008 ; doi : 10. 1016/ j.j ad. 2008.01. 004.
8Kemp DE, Gilmer WS, Fleck J, et al. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia. Prog Neuropsychopharmacol Biol Psychiatry, 2007 ; 31 (2) : 574-577.
9Marcus RN, McQuade RD, Carson WH, et al. Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder. J Clin Psychopharmacology, 2008; 28 (2): 156-165.
10Nylias M, Carson W, Forbes R, et al. Long-term efficacy and safety of aripiprazole in pediatric patients with bipolar disorder. Schizophr Res. 2008 ; 98 ( 1 ) : 48.
